infecti
bronchiti
ib
highli
contagi
avian
diseas
caus
signific
econom
loss
poultri
industri
commerci
loss
mainli
due
decreas
weight
gain
egg
product
poor
egg
qualiti
infecti
bronchiti
viru
ibv
caus
agent
ib
belong
genu
gamma
coronaviru
order
nidoviral
addit
caus
respiratori
diseas
reproduct
system
defect
chicken
nephropathogen
ibv
strain
also
affect
renal
system
caus
nephriti
infect
ibv
complic
opportunist
pathogen
like
e
coli
present
vaccin
util
major
mean
control
ib
live
attenu
inactiv
viru
vaccin
use
protect
chicken
ib
howev
limit
live
attenu
ibv
vaccin
includ
revers
virul
tissu
damag
lead
secondari
bacteri
infect
addit
potenti
interfer
matern
antibodi
vaccin
efficaci
also
taken
consider
moreov
possibl
recombin
virul
strain
vaccin
strain
may
lead
develop
new
pathogen
variant
ibv
hand
inactiv
vaccin
requir
prime
live
attenu
vaccin
larg
dose
adjuv
multipl
vaccin
due
shorter
durat
immun
respons
elev
cost
vaccin
product
limit
applic
although
dna
vaccin
offer
novel
method
immun
induc
cytotox
cell
respons
low
effici
vaccin
limit
applic
field
synthet
peptid
vaccin
alon
immunogen
enough
requir
coadministr
adjuv
therefor
demand
safe
effect
vaccin
control
ib
late
increas
interest
direct
toward
use
nanoparticl
vaccin
infecti
pathogen
vaccin
mimic
variou
properti
viral
pathogen
includ
size
molecular
configur
abil
induc
cellular
humor
immun
selfassembl
protein
nanoparticl
sapn
repres
novel
vaccin
platform
compos
protein
monom
capabl
selfassembl
structur
mimic
size
shape
small
virus
recent
year
demonstr
potenti
sapn
platform
vaccin
success
develop
potent
vaccin
prototyp
sever
acut
respiratori
syndrom
hiv
toxoplasmosi
malaria
influenza
sapn
mani
advantag
vaccin
deliveri
tradit
method
repetit
display
epitop
surfac
genet
fuse
either
n
cterminu
protein
chain
importantli
present
conformationspecif
sequenc
antigen
rapidli
modifi
respons
particular
circul
pathogen
manufactur
easili
scaledup
addit
incorpor
immunostimulatori
molecul
flagellin
pathogen
associ
molecular
pattern
pamp
sapn
gener
selfadjuv
nanoparticl
vaccin
present
studi
develop
selfadjuv
sapn
vaccin
deliveri
antigen
polypeptid
ibv
ibv
posit
nonseg
singlestrand
rna
genom
kb
length
code
four
structur
protein
spike
glycoprotein
membran
protein
envelop
protein
e
nucleocapsid
protein
n
spike
protein
play
essenti
role
attach
viruscel
membran
fusion
host
specif
ibv
infect
ibv
spike
protein
class
fusion
protein
character
format
coiledcoil
structur
consist
two
subunit
outer
membran
anchor
viral
membran
subunit
hypervari
wherea
subunit
rel
conserv
induc
neutral
serotypespecif
antibodi
lack
crossprotect
capac
amongst
differ
strain
subunit
contain
two
heptad
repeat
area
contribut
fusion
process
protein
ibv
signific
antigen
element
induc
neutral
antibodi
vaccin
studi
focus
protein
previou
studi
report
recombin
dna
vaccin
carri
ibv
protein
chicken
interferon
protect
chicken
challeng
massachusett
field
type
ibv
also
success
design
prototyp
vaccin
sar
viru
also
belong
coronavirida
famili
display
high
degre
homolog
ibv
spike
glycoprotein
shown
heptad
repeat
coil
coil
hrc
sequenc
sar
coronaviru
protein
present
sapn
induc
strong
neutral
antibodi
sar
viru
test
vitro
infect
inhibit
assay
base
sequenc
homolog
sar
coronaviru
ibv
studi
investig
potenti
use
selfadjuv
sapn
present
hrc
sequenc
ibv
protein
novel
nanoparticl
vaccin
control
ibv
anim
hous
anim
experi
conduct
strictli
accord
ag
guid
anim
protocol
approv
institut
anim
care
use
committe
univers
connecticut
storr
ct
usa
iacuc
protocol
anim
acclim
one
week
prior
experiment
procedur
chicken
ad
libitum
access
water
feed
monitor
daili
attend
veterinarian
studi
anim
supervis
daili
attend
veterinarian
provid
care
reduc
pain
stress
anim
human
euthan
use
inhal
chamber
accord
approv
protocol
backbon
sapn
monom
design
contain
pentamer
trimer
coil
coil
region
held
togeth
linker
malaria
plasmodium
falciparum
epitop
celto
residu
amino
acid
residu
show
fig
one
monom
monom
fig
design
base
antigen
sequenc
residu
correspond
cterminu
protein
strain
name
ibvsapn
monom
second
monom
contain
domain
residu
flagellin
salmonella
enterica
serovar
typhimurium
place
ibv
antigen
monom
b
fig
name
flagellinsapn
monom
render
nanoparticl
immunogen
two
epitop
akfvaawtlkaaa
haahaahaahaahaa
engin
scaffold
sapn
sequenc
code
construct
codon
optim
express
e
coli
synthes
express
genscript
usa
piscataway
nj
express
purif
carri
previous
describ
briefli
protein
express
pli
l
lb
cultur
supplement
ampicillin
chloramphenicol
express
induc
ad
mm
isopropyl
cultur
reach
h
incub
cultur
pellet
pellet
resuspend
lysi
buffer
urea
mm
tri
base
ph
lyse
sonic
lysat
clear
centrifug
min
clear
lysat
purifi
ml
histrap
hp
column
ge
healthcar
piscataway
nj
use
purifi
ge
healthcar
piscataway
nj
five
column
volum
bind
buffer
urea
mm
mm
imidazol
tri
base
ph
use
equilibr
histrap
hp
column
clear
lysat
load
equilibr
column
underw
wash
volum
bind
buffer
column
wash
column
volum
ph
gradient
phosphat
buffer
ph
buffer
urea
mm
tri
base
ph
buffer
urea
mm
sodium
citrat
ph
buffer
urea
sodium
citrat
ph
ph
buffer
urea
sodium
citrat
ph
final
buffer
urea
mm
tri
base
ph
subsequ
mm
imidazol
gradient
use
elut
protein
column
fraction
eluat
analyz
sdspage
fraction
contain
target
protein
combin
dialyz
overnight
remov
imidazol
prerefold
buffer
urea
mm
nacl
mm
tri
glycerol
ph
protein
concentr
determin
nanodrop
thermo
scientif
wilmington
de
gener
selfadjuv
sapn
ibvflagellinsapn
molar
ratio
ibvsapn
monom
flagellinsapn
monom
establish
base
protein
concentr
establish
molar
ratio
sapn
refold
stepwis
manner
slowli
remov
urea
gradient
urea
concentr
refold
buffer
use
mm
urea
mm
tri
glycerol
ph
sanp
dialyz
hour
concentr
urea
sapn
analyz
previous
describ
sapn
hydrodynam
diamet
measur
dl
c
present
averag
five
run
sapn
absorb
carbon
coat
grid
stain
uranyl
acet
imag
use
fei
tecnai
spirit
biotwin
fourweekold
spf
white
leghorn
chicken
n
charl
river
laboratori
ct
usa
given
vaccin
formul
contain
ibvflagellinsapn
intramuscular
inject
anim
receiv
three
dose
nine
day
interv
day
experi
chicken
bled
vaccin
day
one
experi
bled
three
time
nine
day
immun
day
experi
sera
experiment
chicken
store
c
test
neg
control
flagellinsapn
refold
buffer
use
immun
chicken
chicken
group
immun
protocol
anoth
nonvaccinatednonchalleng
neg
control
group
includ
studi
histopatholog
comparison
chicken
challeng
intranas
ibv
strain
per
chicken
day
age
chicken
observ
daili
clinic
sign
tracheal
swab
sampl
collect
two
four
day
post
challeng
chicken
euthan
four
day
postchalleng
tracheal
swab
place
brain
heart
infus
broth
media
store
test
chicken
group
hous
separ
isol
control
pressur
temperatur
humid
accord
ag
guid
chicken
show
lack
interest
food
water
difficulti
breath
depress
brought
attent
veterinari
staff
anim
care
offic
peripher
blood
mononuclear
cell
pbmc
isol
use
gradient
centrifug
sigma
briefli
ml
blood
mix
equal
amount
pb
bloodpb
mixtur
overlaid
top
equal
volum
centrifug
min
c
opaqu
interfac
collect
wash
twice
pb
centrifug
xg
min
wash
cell
pellet
resuspend
stain
trypan
blue
count
hemocytomet
pbmc
cellswel
plate
cell
cultur
plate
pbmc
stimul
triplic
well
concanavalin
protein
nanoparticl
construct
uvinactiv
ibv
strain
respect
plate
incub
c
hour
prolifer
assay
conduct
use
cell
prolifer
elisa
brdu
colorimetr
kit
roch
appli
scienc
mannheim
germani
briefli
brdu
ad
well
final
concentr
incub
c
plate
centrifug
min
label
medium
remov
flick
plate
airdri
dark
overnight
fixdenat
use
fix
cell
plate
min
c
fix
remov
thoroughli
flick
tap
onehundr
antibrdupod
work
solut
ad
micropl
incub
min
plate
wash
three
time
use
pb
substrat
solut
ad
tmb
tetramethylebenzidin
solut
incub
c
min
color
develop
visibl
reaction
stop
ad
sulfur
acid
well
absorb
measur
background
refer
wavelength
stimul
index
si
calcul
formula
si
od
valu
antigenstimul
pbmc
od
valu
medium
treat
pbmc
elisa
plate
thermo
scientif
usa
coat
contain
synthet
sequenc
fvralsmqildidseidriqgviqglndslidleklsilktyikwpwi
carbonatebicarbon
buffer
ph
overnight
plate
block
bovin
serum
albumin
bsa
pbst
solut
pb
plu
tween
chicken
sera
collect
vaccin
trial
serial
dilut
start
incub
plate
room
temperatur
hour
hyperimmun
sera
use
posit
control
includ
elisa
test
wash
plate
pbst
secondari
antibodi
mous
antichicken
igi
southern
biotech
al
usa
ad
incub
plate
dilut
room
temperatur
hour
plate
wash
elisa
tmb
thermo
scientif
substrat
appli
well
room
temperatur
minut
color
develop
reaction
stop
hcl
plate
read
absorb
nm
three
nine
dayold
spf
embryon
chicken
egg
inocul
allanto
caviti
filter
steril
tracheal
swab
egg
incub
five
day
egg
observ
daili
embryo
mortal
egg
kept
fifth
day
postinocul
allanto
fluid
harvest
rna
extract
tracheal
swab
recov
allanto
fluid
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
first
strand
cdna
synthes
revers
transcript
reaction
rt
use
high
capac
cdna
revers
transcriptas
kit
appli
biosystem
usa
total
rna
ng
use
reaction
contain
dntp
reaction
buffer
random
primer
enzym
mix
accord
manufactur
instruct
rt
reaction
conduct
thermocycl
appli
biosystem
program
profil
c
min
c
min
c
min
real
time
rtpcr
perform
previous
describ
reaction
mix
prepar
master
mix
sybr
green
pcr
master
mix
appli
biosystem
pmole
forward
revers
primer
forward
aca
ggt
tct
ggt
ggt
gtt
tag
tg
revers
agt
tgt
tcg
gga
atg
tct
ttg
g
cdna
templat
nucleasefre
water
ad
bring
volum
reaction
run
use
biorad
real
time
pcr
system
cfx
cycl
profil
c
min
cycl
c
c
c
melt
temperatur
determin
c
c
heat
ramp
cs
tracheal
tissu
harvest
euthanasia
necropsi
four
day
post
challeng
fix
neutral
formalin
hematoxylin
eosin
stain
perform
cross
section
tracheal
tissu
score
scale
establish
modif
previous
describ
score
method
data
analyz
use
one
twoway
anova
bonferroni
posttest
graphpad
prism
statist
signific
achiev
level
p
valu
gene
ibvsapn
monom
flagellinsapn
monom
success
synthes
subclon
plasmid
fig
sdspage
refold
sapn
reveal
ibvflagellinsapn
flagellinsapn
show
high
puriti
expect
molecular
weight
kda
kda
two
type
protein
chain
fig
dynam
light
scatter
show
hydrodynam
diamet
nm
nm
ibvflagellinsapn
flagellinsapn
respect
confirm
transmiss
electron
microscopi
fig
test
antibodi
respons
elicit
sapn
elisa
perform
use
plate
coat
synthet
peptid
result
show
markedli
elev
antibodi
respons
chicken
vaccin
ibvflagellinsapn
fig
flagellinsapn
buffer
control
chicken
group
detect
antibodi
respons
fig
booster
effect
observ
chicken
primevaccin
ibvflagellinsapn
indic
elev
antibodi
level
addit
dosag
fig
result
demonstr
ibvflagellinsapn
vaccin
induc
humor
immun
respons
chicken
stimul
pbmc
chicken
immun
ibvflagellinsapn
sapn
fig
inactiv
ibv
viru
fig
result
significantli
higher
prolifer
correspond
pbmc
neg
control
group
flagellinsapn
demonstr
induct
cellular
immun
respons
gener
memori
pool
vaccin
evalu
vaccin
effect
restrict
viru
replic
viral
copi
number
measur
qrtpcr
trachea
immun
neg
control
chicken
challeng
ibv
signific
reduct
viru
shed
trachea
found
four
day
post
challeng
ibvflagllinsapn
compar
flagellinsapn
buffer
group
fig
interestingli
chicken
inocul
neg
control
construct
flagellinsapn
also
lower
level
viru
shed
buffer
inocul
group
signific
reduct
viru
induc
flagellinsapn
found
two
day
post
challeng
fig
rule
infer
noninfecti
viru
result
also
inocul
embryon
egg
tracheal
swab
materi
quantifi
rna
copi
number
recov
viru
real
time
rtpcr
interestingli
found
rna
copi
number
recov
group
receiv
sapn
ibvflagellinsapn
flagellinsapn
lower
buffer
control
group
indic
level
restrict
viru
replic
chicken
sapn
treatment
fig
significantli
lower
viral
load
observ
ibvflagellinsapn
group
two
day
four
day
inocul
embryon
egg
compar
buffer
control
flagellinsapn
group
fig
restrict
progress
diseas
direct
indic
prophylact
effect
test
vaccin
candid
evalu
vaccineinduc
protect
score
microscop
lesion
tracheal
tissu
day
post
challeng
four
grade
scale
fig
observ
histolog
tracheal
tissu
chicken
vaccin
ibvflagellinsapn
group
quit
similar
tracheal
tissu
histolog
nonvaccinatednonchalleng
group
ibvflagellinsapn
group
significantli
lesser
tracheal
lesion
score
flagellinsapn
group
buffer
control
group
fig
result
consist
viru
shed
trachea
record
four
day
challeng
suggest
protect
efficaci
ibvflagellinsapn
vaccin
vaccin
larg
use
measur
control
ibv
year
howev
challeng
remain
current
avail
live
attenu
kill
vaccin
effect
combat
rapidli
emerg
variant
strain
gener
point
mutat
recombin
event
addit
live
attenu
vaccin
still
predomin
vaccin
use
use
rais
concern
safeti
contribut
emerg
new
pathogen
ibv
variant
studi
live
vaccin
efficaci
chicken
show
immun
respons
expos
ibv
even
rais
environment
condit
differ
depend
chicken
genet
highli
variabl
kill
vaccin
anoth
current
commerci
option
ibv
protect
vaccin
appear
elicit
much
protect
respiratori
tract
less
chicken
studi
display
tracheal
immun
peptid
subunit
vaccin
may
safer
usual
poorli
immunogen
use
alon
nanoparticl
technolog
demonstr
promis
deliveri
system
improv
drug
efficaci
nevertheless
still
issu
challeng
develop
nanoparticl
vaccin
deliveri
system
one
hand
cytotox
nanoparticl
like
titanium
oxid
gold
cation
lipid
major
problem
hand
maintain
antigen
stabil
correctli
display
antigen
nativ
conform
surfac
nanoparticl
may
challeng
contrast
sapn
demonstr
innov
method
vaccin
design
repetit
display
antigen
epitop
nativ
conform
success
appli
construct
vaccin
induc
robust
immun
respons
numer
pathogen
includ
malaria
influenza
sar
toxoplasma
hiv
present
studi
develop
sapn
base
ibv
vaccin
candid
repetit
present
ibv
antigen
vaccin
malaria
epitop
celto
includ
design
render
sapn
biophys
wellbehav
base
previou
experi
celtoscontain
sapn
nice
solubl
form
spheric
particl
therefor
otherwis
unrel
malaria
protein
includ
design
ib
vaccin
benefici
vaccin
also
contain
bioactiv
domain
flagellin
selfadjuv
vaccin
render
immunogen
success
appli
system
influenza
malaria
toxoplasmosi
achiev
signific
improv
immunogen
test
term
antibodi
respons
diseas
current
studi
expand
selfadjuv
sapn
technolog
use
avian
infecti
bronchiti
spike
protein
subunit
differ
virus
use
vaccin
studi
success
newcastl
diseas
viru
instanc
modifi
express
subunit
found
provid
protect
compar
commerci
vaccin
two
vaccin
similar
observ
found
use
baculoviru
fowl
adenoviru
vector
ibv
coronaviru
protein
consid
main
viru
attach
protein
contain
critic
neutral
epitop
thu
make
ideal
vaccin
compon
induc
protect
coronavirus
inde
sever
studi
suggest
protein
could
serv
major
target
vaccin
design
coronavirus
protein
subunit
express
surfac
ibv
promis
immunogen
provid
increas
crossprotect
variou
serotyp
sinc
highli
conserv
region
hr
region
coronaviru
protein
trimer
coiledcoil
therefor
vaccin
display
hr
nativ
trimer
coiledcoil
conform
would
perform
well
chicken
previou
research
show
sapn
repetit
display
sar
coronaviru
bcell
epitop
ctermin
hr
viru
spike
protein
abl
neutral
sarscoronaviru
infect
base
homolog
sarscoronaviru
ibv
protein
hypothes
equival
region
ibv
would
similar
vaccin
potenti
present
studi
sapn
repetit
display
ibv
protein
induc
notic
high
level
antibodi
respons
initi
result
demonstr
prototyp
ibvflagellinsapn
nanoparticl
vaccin
abl
induc
strong
humor
immun
respons
vaccin
chicken
repetit
display
b
cell
epitop
essenti
enhanc
humor
immun
respons
result
studi
support
appropri
epitop
repetit
display
like
nativ
trimer
conform
sapn
vaccin
evidenc
rel
strong
antibodi
respons
elicit
chicken
furthermor
ibvflagellinsapn
vaccin
significantli
stimul
cellular
immun
gener
memori
pool
demonstr
respons
pbmc
vaccin
chicken
recal
antigen
stimul
current
studi
protect
higher
group
chicken
vaccin
ibvflagellinsapn
control
group
flagellin
sapn
buffer
group
also
viral
rna
load
trachea
significantli
lower
compar
control
group
four
day
challeng
consist
significantli
lesser
tracheal
lesion
score
four
day
challeng
chicken
vaccin
ibvflagellinsapn
flagellin
sapn
buffer
group
microscop
evalu
reveal
major
patholog
chang
trachea
ibvflagellin
sapn
vaccin
chicken
histolog
compar
nonvaccinatednonchalleng
control
group
clear
indic
vaccin
induc
protect
result
consist
report
previous
chicken
vaccin
recombin
sectodomain
protein
vaccin
elicit
protect
ibv
challeng
suggest
domain
crucial
role
persuad
protect
immun
eldemeri
et
al
basi
viral
rna
load
trachea
tracheal
histopatholog
assess
ibvflagellinsapn
vaccin
shown
clear
potenti
protect
chicken
challeng
ibv
without
coadministr
commerci
adjuv
howev
kept
mind
experiment
vaccin
previou
data
exist
use
platform
particular
ibv
antigen
make
comparison
therefor
work
conduct
provid
proof
principl
vaccin
immunogen
demonstr
shown
measur
antibodi
cellular
respons
level
protect
clearli
demonstr
vaccin
chicken
current
studi
incorpor
flagellin
sapn
immunostimulatori
molecul
gener
selfadjuv
sapn
flagellin
extens
explor
use
adjuv
variou
kind
vaccin
formul
includ
solubl
mixtur
protein
coexpress
epitop
encod
dna
vaccin
interest
flagellinsapn
abl
significantli
reduc
viral
shed
trachea
inocul
chicken
challeng
ibv
fig
chicken
inocul
flagellinsapn
also
significantli
lesser
lesion
score
tracheal
tissu
chicken
inocul
buffer
fig
protect
effect
flagellinsapn
may
attribut
nonspecif
activ
natur
killer
cell
macrophag
recruit
heterophil
lead
limit
restrict
viru
replic
observ
accord
fact
flagellin
induc
proinflammatori
cytokin
account
antivir
effect
data
support
intrins
qualiti
vaccin
backbon
signific
asset
level
protect
ibvflagellinsapn
vaccin
still
significantli
higher
flagellinsapn
base
paramet
data
suggest
success
implement
selfadjuv
sapn
use
vaccin
backbon
ibv
although
nanoparticl
vaccin
structur
effect
deliv
subunit
peptid
peptid
mixtur
subunit
compon
nanoparticl
may
investig
improv
vaccin
perform
immunogen
effect
backbon
sapn
effect
versatil
backbon
enabl
us
explor
addit
viral
antigen
enhanc
vaccin
efficaci
eventu
appli
control
diseas
